SCHEDULE 13D

Company

Ascendis Pharma A/S

Filed

February 12, 2015

Accession Number

0000947871-15-000106

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →